Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ovid Therapeutics (OVID) Change in Account Payables (2016 - 2026)

Ovid Therapeutics filings provide 11 years of Change in Account Payables readings, the most recent being $3.6 million for Q1 2026.

  • Quarterly Change in Account Payables rose 391.79% to $3.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.6 million through Mar 2026, up 320.52% year-over-year, with the annual reading at -$1.2 million for FY2025, 141.02% down from the prior year.
  • Change in Account Payables hit $3.6 million in Q1 2026 for Ovid Therapeutics, up from $246000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $3.6 million in Q1 2026 and bottomed at -$4.9 million in Q1 2022.
  • Average Change in Account Payables over 5 years is -$90949.2, with a median of $246000.0 recorded in 2025.
  • The largest annual shift saw Change in Account Payables skyrocketed 718.54% in 2022 before it plummeted 1060.75% in 2025.
  • Ovid Therapeutics' Change in Account Payables stood at $919844.0 in 2022, then skyrocketed by 170.26% to $2.5 million in 2023, then tumbled by 80.65% to $481000.0 in 2024, then crashed by 48.86% to $246000.0 in 2025, then soared by 1373.17% to $3.6 million in 2026.
  • Per Business Quant, the three most recent readings for OVID's Change in Account Payables are $3.6 million (Q1 2026), $246000.0 (Q4 2025), and -$2.2 million (Q3 2025).